+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Propranolol"

Anti-Ischemic Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Ischemic Agents - Global Strategic Business Report

  • Report
  • April 2025
  • 94 Pages
  • Global
From
Beta Blockers Market Report 2025 - Product Thumbnail Image

Beta Blockers Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Vascular Anomalies - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Anomalies - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Propranolol is a beta-blocker drug used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. It works by blocking the action of certain natural chemicals in the body, such as epinephrine, that affect the heart and blood vessels. Propranolol is also used to treat certain types of tremors, and to prevent migraine headaches. It is available in both oral and intravenous forms. Propranolol is one of the most commonly prescribed cardiovascular drugs, and is widely used in the treatment of hypertension, angina, and arrhythmias. It is also used to treat certain types of tremors, and to prevent migraine headaches. It is generally well tolerated, with few side effects. The propranolol market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more